Search results for "biotech"
Article
Modeling and Miniaturization: Key Topics at Successful HTPD Conference
The first session also contained one appreciated talk from outside the core field, with Luis Cascão-Pereira from DuPont talking about white biotechnology and process development of enzymes used for wa…
Article
The New World of Biopharmaceutical Manufacturing
…sing, Pall Life Sciences; Fritjof Linz, vice-president, Purification Technologies, Sartorius Stedim Biotech; and Eva Heintz, global market manager, Healthcare, at Solvay Specialty Polymers about adva…
Article
From Darwin to Recombinant Fc Multimers
The conference attendees of the 10th Plasma Product Biotechnology meeting on Malta provided a wide spectrum of topics from May 15-18.
The Plasma Product Biotechnology (PPB) meeting series is a joi…
Article
Unifying Continuous Biomanufacturing Operations
According to language in the patent, “The invention allows providing third-world countries with national production systems and also enables pharmaceutical companies without [a] biotech background to …
Article
Witnessing Major Growth in Next-Generation Antibodies
Both large and small pharmaceutical and biotech companies are pursuing these newer therapies. A few have already been approved, and many more are in preclinical and clinical development. There are num…
Article
Single-use Bioreactors Have Reached the Big Time
In other words, does adoption of single-use or stainless-steel bioreactor technology provide greater advantages?” observes Thorsten Adams, director of product management with Sartorius Stedim Biotech.…
Article
Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
The year ahead is expected to be marked by increased biosimilar development, lower drug prices, and better quality drugs.
The global biopharmaceuticals market was valued at $162 billion in 2014 a…
Article
The Tide Stays High
Equity markets’ appetite for public offerings from emerging bio/pharmaceutical companies had significantly diminished: valuations of emerging bio/pharma companies, as measured by the NASDAQ Biotechnol…
Article
Biosimilars to Drive Modern Manufacturing Approaches
By Jill Wechsler
As more biosimilars gain market approval in the United States, and manufacturers launch additional programs to develop competitive biotech therapies, regulatory authorities and in…
Article
Generating a Fully Processed Antibody
The authors outline cell-line development and process scale-up for an antibody program in which the antibody requires additional processing by a site-specific enzyme for correct functionality.
B…